Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person paricalcitol [nucleoplasm]

Class:Id	ChemicalDrug:9660179
_displayName	paricalcitol [nucleoplasm]
_timestamp	2019-09-09 14:12:43
compartment	[Compartment:7660] nucleoplasm
created	[InstanceEdit:9660123] Jassal, Bijay, 2019-09-09
crossReference	[DatabaseIdentifier:9660207] ChEBI:7931
disease	[Disease:9660203] secondary hyperparathyroidism
literatureReference	[LiteratureReference:9660124] Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials [LiteratureReference:9660202] Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
name	paricalcitol
referenceEntity	[ReferenceTherapeutic:9660220] paricalcitol [Guide to Pharmacology:2791]
stableIdentifier	[StableIdentifier:9660230] R-ALL-9660179.1
(hasMember)	[DefinedSet:9660116] VDR agonists [nucleoplasm]
[Change default viewing format]

No pathways have been reviewed or authored by paricalcitol [nucleoplasm] (9660179)